Tuhura Biosciences Inc. has announced updated compensation terms for its top executives. Effective June 6, 2025, the company's Compensation Committee approved an increase in the annual base salaries of James A. Bianco, M.D., Chief Executive Officer, to $577,101, and Dan Dearborn, Chief Financial Officer, to $384,453. Additionally, the Committee has finalized the fiscal year 2024 annual incentive bonuses for these executives, reflecting adjustments based on compensation practices and trends from a peer group analysis. The revised compensation aims to align the executives' salaries to approximately 90% of the 50th percentile of base salary levels within their peer group.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.